RxDoctor Payments Data

Tom Yao, MD

Neurological Surgery · Louisville, KYNPI 1235286113

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $342,129 of the $404,819 with a category attached, or 84.5%. Microvention, Inc. accounts for 93.1% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2020 at $106,781 and has fallen 78.8% since, to $22,603 in 2025. Among neurological surgery clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$404,819in general payments, 2019–2025

Across 418 payments — averaging $968.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Microvention, Inc.$377K
  • Medical Device Business Services, Inc.$9K
  • Medtronic$9K
  • Ischemaview, Inc.$8K
  • Stryker$857
  • Johnson & Johnson$493
  • plus $1K from 13 others
$204,563in research payments, 2019–2025

Across 96 payments — averaging $2130.87 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Microvention, Inc.$98K
  • Medical Device Business Services, Inc.$67K
  • Medtronic$23K
  • Penumbra, Inc.$17K

What the payments were for

  • Consulting fees$37,2999%
  • Speaking & faculty fees$342,12985%
  • Travel & lodging$17,5304%
  • Food & beverage$7,8412%
  • Education$200%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$404,819 in reported general payments places this provider in the 95th percentile of 99 neurological surgery providers in Kentucky.

See all neurological surgery providers in Kentucky

Medicare billing

Part B allowed, 2024
$170,504
Medicare patients
253
Services billed
709

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate15$105

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →